Stockreport

CohBar up 27% on resumption of clinical trial for lead candidate [Seeking Alpha]

CohBar, Inc.  (CWBR) 
NASDAQ:AMEX Investor Relations: ir.cohbar.com
PDF CohBar up 27% on resumption of clinical trial for lead candidate Thinly traded micro cap CohBar ( CWBR +27.1% resumption The study was temporarily suspended The company [Read more]